Subscribe
megaflopp / Shutterstock.com
23 July 2024NewsAmericasLiz Hockley

US targets ‘product hopping’ with biologic litigation curbs

House of Representatives introduces bill to drive down cost of prescription drugs | Places “reasonable limit” on the number of patents a manufacturer can contest to prevent patent ‘thickets’ | Companion bill passed Senate earlier this month.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.

More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024   As SCOTUS pulls away from deference to federal agencies, issues such as non-competes and terminal disclaimers could be on shaky ground, finds Muireann Bolger.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent